Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 65
Filter
Add more filters

Publication year range
1.
Microvasc Res ; 135: 104136, 2021 05.
Article in English | MEDLINE | ID: mdl-33450295

ABSTRACT

Reversine, or 2-(4-morpholinoanilino)-6cyclohexylaminopurine, is a 2,6-disubstituted purine derivative. This small molecule exhibits tumor-suppressive activities through different molecular mechanisms. In this study, in vitro and in vivo angiogenic models were used to elucidate the effect of Reversine on angiogenesis in the tumor suppression. Firstly, we grafted osteosarcoma-derived MNNG/HOS cell aggregates onto chick embryonic chorioallantoic membrane (CAM) to examine the vascularization of these grafts following Reversine treatment. Following culture, it was determined that Reversine inhibited MNNG/HOS grafts growth, and decreased the density of blood vessels in the chick CAM. We then used CAM and chick embryonic yolk-sac membrane (YSM) to investigate the effects of Reversine on angiogenesis. The results revealed Reversine inhibited the proliferation of endothelial cells, where cells were mainly arrested at G1/S phase of the cell cycle. Scratch-wound assay with HUVECs revealed that Reversine suppressed cell migration in vitro. Furthermore, endothelial cells tube formation assay and chick aortic arch sprouting assay demonstrated Reversine inhibited the sprouting, migration of endothelial cells. Lastly, qPCR and western blot analyses showed BMP-associated Smad1/5/8 signaling expressions were up-regulated by Reversine treatment. Our results showed that Reversine could suppress tumor growth by inhibiting angiogenesis through BMP signaling, and suggests a potential use of Reversine as an anti-tumor therapy.


Subject(s)
Angiogenesis Inhibitors/pharmacology , Bone Morphogenetic Proteins/metabolism , Bone Neoplasms/drug therapy , Cell Proliferation/drug effects , Human Umbilical Vein Endothelial Cells/drug effects , Morpholines/pharmacology , Neovascularization, Physiologic/drug effects , Osteosarcoma/drug therapy , Purines/pharmacology , Smad Proteins/metabolism , Animals , Bone Morphogenetic Proteins/genetics , Bone Neoplasms/metabolism , Bone Neoplasms/pathology , Cell Line, Tumor , Chick Embryo , G1 Phase Cell Cycle Checkpoints/drug effects , Human Umbilical Vein Endothelial Cells/metabolism , Humans , Osteosarcoma/metabolism , Osteosarcoma/pathology , Signal Transduction , Smad Proteins/genetics , Smad1 Protein/metabolism , Smad2 Protein/metabolism , Smad3 Protein/metabolism
2.
Zygote ; 26(6): 457-464, 2018 Dec.
Article in English | MEDLINE | ID: mdl-30520400

ABSTRACT

SummaryFibroblast growth factor (FGF) signalling acts as one of modulators that control neural crest cell (NCC) migration, but how this is achieved is still unclear. In this study, we investigated the effects of FGF signalling on NCC migration by blocking this process. Constructs that were capable of inducing Sprouty2 (Spry2) or dominant-negative FGFR1 (Dn-FGFR1) expression were transfected into the cells making up the neural tubes. Our results revealed that blocking FGF signalling at stage HH10 (neurulation stage) could enhance NCC migration at both the cranial and trunk levels in the developing embryos. It was established that FGF-mediated NCC migration was not due to altering the expression of N-cadherin in the neural tube. Instead, we determined that cyclin D1 was overexpressed in the cranial and trunk levels when Sprouty2 was upregulated in the dorsal neural tube. These results imply that the cell cycle was a target of FGF signalling through which it regulates NCC migration at the neurulation stage.


Subject(s)
Chick Embryo/cytology , Chick Embryo/metabolism , Fibroblast Growth Factors/metabolism , Neural Crest/cytology , Animals , Cadherins/genetics , Cadherins/metabolism , Cell Movement , Cyclin D1/genetics , Cyclin D1/metabolism , Gene Expression Regulation, Developmental , Nerve Tissue Proteins/genetics , Nerve Tissue Proteins/metabolism , Neural Crest/metabolism , Neural Tube/embryology , Neural Tube/metabolism , Receptor, Fibroblast Growth Factor, Type 1/genetics , Receptor, Fibroblast Growth Factor, Type 1/metabolism , Signal Transduction
3.
J Cell Mol Med ; 21(7): 1361-1372, 2017 07.
Article in English | MEDLINE | ID: mdl-28158928

ABSTRACT

Activation of osteoblasts in bone formation and osteoclasts in bone resorption is important during the bone fracture healing process. There has been a long interest in identifying and developing a natural therapy for bone fracture healing. In this study, we investigated the regulation of osteoclast differentiation by baicalin, which is a natural molecule extracted from Eucommiaulmoides (small tree native to China). It was determined that baicalin enhanced osteoclast maturation and bone resorption activity in a dose-dependent manner. Moreover, this involves the activation of MAPK, increased Mitf nuclear translocation and up-regulation of downstream osteoclast-related target genes expression. The baicalin-induced effect on osteoclast differentiation can be mimicked by specific inhibitors of p-ERK (U0126) and the Mitf-specific siRNA, respectively. Protein-ligand docking prediction identified that baicalin might bind to RANK, which is the upstream receptor of p-ERK/Mitf signalling in osteoclasts. This indicated that RANK might be the binding target of baicalin. In sum, our findings revealed baicalin increased osteoclast maturation and function via p-ERK/Mitf signalling. In addition, the results suggest that baicalin can potentially be used as a natural product for the treatment of bone fracture.


Subject(s)
Flavonoids/administration & dosage , Fractures, Bone/drug therapy , MAP Kinase Kinase 1/genetics , Microphthalmia-Associated Transcription Factor/genetics , Receptor Activator of Nuclear Factor-kappa B/genetics , Animals , Bone Resorption/genetics , Bone Resorption/physiopathology , Butadienes/administration & dosage , Cell Differentiation/drug effects , Fractures, Bone/genetics , Fractures, Bone/physiopathology , Humans , MAP Kinase Kinase 1/antagonists & inhibitors , Mice , Microphthalmia-Associated Transcription Factor/antagonists & inhibitors , Nitriles/administration & dosage , Osteoclasts/drug effects , Osteoclasts/metabolism , Osteogenesis/genetics , Protein Binding , RAW 264.7 Cells , Signal Transduction/drug effects
4.
J Appl Toxicol ; 36(2): 285-95, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26179615

ABSTRACT

It is now known that over-consumption of caffeine by pregnant mothers could have detrimental effects on normal fetal development. However, it remains obscure how caffeine's harmful effect impacts directly or indirectly on the developing embryo/fetus through damaging placenta development. In this study, we demonstrated the morphological similarities between the yolk sac and chorioallantoic membranes (CAM) of chick embryos and the villi of the mammalian placenta. Using the chick yolk sac and the CAM as a model, we found that 5-15 Āµmol per egg of caffeine exposure inhibited angiogenesis. Under the same condition, cell proliferation in extraembryonic mesoderm was reduced while apoptosis was enhanced. Semi-quantitative RT-PCR analysis revealed that caffeine treatment down-regulated VEGF, VEGFR2, PIGF, IGF2 and NRP1 expression, but up-regulated Ang1 and Ang2 expression. We performed in situ hybridization to show VE-cadherin expression and as to demonstrate the blood vessels in the CAM and yolk sac membranes. This distribution of the VE-cadherin(+) blood vessels was determined to be reduced after caffeine treatment. Furthermore, MDA activity was induced after caffeine exposure, but GSH-PX activity was inhibited after caffeine exposure; SOD activity was unchanged as compared with the control. In summary, our results suggest that caffeine exposure could negatively impact on angiogenesis in the chick yolk sac and CAM by targeting angiogenesis-related genes. Some of these genes are also involved in regulating excess ROS generation. The results implied that the negative impact of caffeine on fetal development was partly attributed to impaired placental angiogenesis.


Subject(s)
Blood Vessels/drug effects , Caffeine/toxicity , Fetal Development/drug effects , Mammals/growth & development , Placenta/drug effects , Reproduction/drug effects , Yolk Sac/drug effects , Animals , Chickens , Female , Models, Animal , Pregnancy
5.
J Appl Toxicol ; 36(5): 692-701, 2016 May.
Article in English | MEDLINE | ID: mdl-26177723

ABSTRACT

It is now known that excess alcohol consumption during pregnancy can cause fetal alcohol syndrome to develop. However, it is not known whether excess ethanol exposure could directly affect angiogenesis in the embryo or angiogenesis being indirectly affected because of ethanol-induced fetal alcohol syndrome. Using the chick yolk sac membrane (YSM) model, we demonstrated that ethanol exposure dramatically inhibited angiogenesis in the YSM of 9-day-old chick embryos, in a dose-dependent manner. Likewise, the anti-angiogenesis effect of ethanol could be seen in the developing vessel plexus (at the same extra-embryonic regions) during earlier stages of embryo development. The anti-angiogenic effect of ethanol was found associated with excess reactive oxygen species (ROS) production; as glutathione peroxidase activity increased while superoxide dismutase 1 and 2 activities decreased in the YSMs. We further validated this observation by exposing chick embryos to 2,2'-azobis-amidinopropane dihydrochloride (a ROS inducer) and obtained a similar anti-angiogenesis effect as ethanol treatment. Semiquantitative reverse transcription-polymerase chain reaction analysis of the experimental YSMs revealed that expression of angiogenesis-related genes, vascular endothelial growth factor and its receptor, fibroblast growth factor 2 and hypoxia-inducible factor, were all repressed following ethanol and 2,2'-azobis-amidinopropane dihydrochloride treatment. In summary, our results suggest that excess ethanol exposure inhibits embryonic angiogenesis through promoting superfluous ROS production during embryo development.


Subject(s)
Angiogenesis Inhibitors/toxicity , Embryo, Nonmammalian/drug effects , Ethanol/toxicity , Neovascularization, Physiologic/drug effects , Amidines/toxicity , Animals , Cardiovascular System/drug effects , Cardiovascular System/embryology , Chick Embryo , Dose-Response Relationship, Drug , Embryonic Development/drug effects , Fibroblast Growth Factor 2/genetics , Fibroblast Growth Factor 2/metabolism , Human Umbilical Vein Endothelial Cells/drug effects , Humans , Reactive Oxygen Species/metabolism , Receptors, Vascular Endothelial Growth Factor/genetics , Receptors, Vascular Endothelial Growth Factor/metabolism , Superoxide Dismutase/genetics , Superoxide Dismutase/metabolism , Superoxide Dismutase-1/genetics , Superoxide Dismutase-1/metabolism , Vascular Endothelial Growth Factor A/genetics , Vascular Endothelial Growth Factor A/metabolism , Yolk Sac/drug effects
6.
Exp Cell Res ; 320(2): 354-64, 2014 Jan 15.
Article in English | MEDLINE | ID: mdl-24162003

ABSTRACT

1,1-Dimethyl-4-phenyl piperazine iodide (DMPP) is a synthetic nicotinic acetylcholine receptor (nAChR) agonist that could reduce airway inflammation. In this study, we demonstrated that DMPP could dramatically inhibit glioma size maintained on the chick embryonic chorioallantoic membrane (CAM). We first performed MTT and BrdU incorporation experiments on U87 glioma cells in vitro to understand the mechanism involved. We established that DMPP did not significantly affect U87 cell proliferation and survival. We speculated that DMPP directly caused the tumor to regress by affecting the vasculature in and around the implanted tumor on our chick CAM model. Hence, we conducted detailed analysis of DMPP's inhibitory effects on angiogenesis. Three vasculogenesis and angiogenesis in vivo models were used in the study which included (1) early chick blood islands formation, (2) chick yolk-sac membrane (YSW) and (3) CAM models. The results revealed that DMPP directly suppressed all developmental stages involved in vasculogenesis and angiogenesis - possibly by acting through Ang-1 and HIF-2α signaling. In sum, our results show that DMPP could induce glioma regression grown on CAM by inhibiting vasculogenesis and angiogenesis.


Subject(s)
Dimethylphenylpiperazinium Iodide/pharmacology , Glioma/blood supply , Glioma/pathology , Neovascularization, Pathologic/prevention & control , Animals , Cell Proliferation/drug effects , Cell Survival/drug effects , Chick Embryo , Humans , Remission Induction , Tumor Burden/drug effects , Tumor Cells, Cultured , Yolk Sac/blood supply , Yolk Sac/drug effects
7.
J Cell Mol Med ; 18(6): 1134-43, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24636305

ABSTRACT

Caffeine has been an integral component of our diet and medicines for centuries. It is now known that over consumption of caffeine has detrimental effects on our health, and also disrupts normal foetal development in pregnant mothers. In this study, we investigated the potential teratogenic effect of caffeine over-exposure on eye development in the early chick embryo. Firstly, we demonstrated that caffeine exposure caused chick embryos to develop asymmetrical microphthalmia and induced the orbital bone to develop abnormally. Secondly, caffeine exposure perturbed Pax6 expression in the retina of the developing eye. In addition, it perturbed the migration of HNK-1(+) cranial neural crest cells. Pax6 is an important gene that regulates eye development, so altering the expression of this gene might be the cause for the abnormal eye development. Thirdly, we found that reactive oxygen species (ROS) production was significantly increased in eye tissues following caffeine treatment, and that the addition of anti-oxidant vitamin C could rescue the eyes from developing abnormally in the presence of caffeine. This suggests that excess ROS induced by caffeine is one of the mechanisms involved in the teratogenic alterations observed in the eye during embryogenesis. In sum, our experiments in the chick embryo demonstrated that caffeine is a potential teratogen. It causes asymmetrical microphthalmia to develop by increasing ROS production and perturbs Pax6 expression.


Subject(s)
Caffeine/toxicity , Central Nervous System Stimulants/toxicity , Embryonic Development/drug effects , Microphthalmos/pathology , Orbital Diseases/pathology , Organogenesis/drug effects , Retina/pathology , Animals , Chick Embryo , Eye Proteins/metabolism , Female , Homeodomain Proteins/metabolism , Immunoenzyme Techniques , Microphthalmos/chemically induced , Microphthalmos/embryology , Orbital Diseases/chemically induced , Orbital Diseases/embryology , Paired Box Transcription Factors/metabolism , Pregnancy , Retina/drug effects , Retina/embryology
8.
Apoptosis ; 19(5): 829-40, 2014 May.
Article in English | MEDLINE | ID: mdl-24395041

ABSTRACT

Brain and Reproductive Organ Expressed (BRE), or BRCC45, is a death receptor-associated antiapoptotic protein, which is also involved in DNA-damage repair, and K63-specific deubiquitination. BRE overexpression attenuates both death receptor- and stress-induced apoptosis, promotes experimental tumor growth, and is associated with human hepatocellular and esophageal carcinoma. How BRE mediates its antiapoptotic function is unknown. Here we report based on the use of a mouse Lewis lung carcinoma cell line D122 that BRE has an essential role in maintaining the cellular protein level of XIAP, which is the most potent endogenous inhibitor of the caspases functioning in both extrinsic and intrinsic apoptosis. shRNA-mediated exhaustive depletion of BRE sensitized D122 cells to apoptosis induced not only by etopoxide, but also by TNF-α even in the absence of cycloheximide, which blocks the synthesis of antiapoptotic proteins by TNF-α-activated NF-κB pathway. In BRE-depleted cells, protein level of XIAP was downregulated, but not the levels of other antiapoptotic proteins, cIAP-1, 2, and cFLIP, regulated by the same NF-κB pathway. Reconstitution of BRE restored XIAP levels and increased resistance to apoptosis. XIAP mRNA level was also reduced in the BRE-depleted cells, but the level of reduction was less profound than that of the protein level. However, BRE could not delay protein turnover of XIAP. Depletion of BRE also increased tumor cell apoptosis, and decreased both local and metastatic tumor growth. Taken together, these findings indicate that BRE and its XIAP-sustaining mechanism could represent novel targets for anti-cancer therapy.


Subject(s)
Apoptosis/physiology , Carcinoma, Lewis Lung/metabolism , Caspase Inhibitors/metabolism , Nerve Tissue Proteins/metabolism , X-Linked Inhibitor of Apoptosis Protein/metabolism , Animals , Carcinoma, Lewis Lung/pathology , Cell Line, Tumor , Cell Proliferation , Mice , Mice, Inbred C57BL , Nuclear Proteins , X-Linked Inhibitor of Apoptosis Protein/genetics
9.
Toxicol Appl Pharmacol ; 281(1): 19-29, 2014 11 15.
Article in English | MEDLINE | ID: mdl-25286332

ABSTRACT

Dexamethasone (Dex) has anti-inflammatory and immunomodulatory properties against many conditions. There is a potential teratogenic risk, however, for pregnant women receiving Dex treatment. It has been claimed that Dex exposure during pregnancy could affect osteogenesis in the developing embryo, which still remains highly controversial. In this study, we employed chick embryos to investigate the effects of Dex exposure on skeletal development using combined in vivo and in vitro approach. First, we demonstrated that Dex (10(-8)-10(-6)Āµmol/egg) exposure resulted in a shortening of the developing long bones of chick embryos, and it accelerated the deposition of calcium salts. Secondly, histological analysis of chick embryo phalanxes exhibited Dex exposure inhibited the proliferation of chondrocytes, increased apoptosis of chondrocytes and osteocytes, and led to atypical arranged hypertrophic chondrocytes. The expression of genes related to skeletogenesis was also analyzed by semi-quantitative RT-PCR. The expression of ALP, Col1a2 and Col2a1 was decreased in the Dex treated phalanxes. A detectable increase was observed in Runx-2 and Mmp-13 expression. We next examined how Dex affected the different stages of skeletogenesis in vitro. Utilizing limb bud mesenchyme micromass cultures, we determined that Dex exposure exerted no effect on apoptosis but impaired chondrogenic cell proliferation. Interestingly, low dose of Dex moderately prompted nodule formation as revealed by alcian blue staining, but higher doses of Dex significantly inhibited similar chondrogenic differentiation. Dex exposure did not induce apoptosis when the chondrogenic precursors were still at the mesenchymal stage, however, cell viability was suppressed when the mesenchyme differentiated into chondrocytes. Alizarin red staining revealed that the capacity to form mineralized bone nodules was correspondingly enhanced as Dex concentrations increased. The mRNA level of Sox-9 was slightly increased in mesenchymal cell mass treated by low concentration of Dex. Mmp-13 expression was obviously up-regulated by Dex in both mesenchymal cells and primary chondrocyte cultures. And Col10a1 expression was also increased by Dex exposure in chondrocyte. In summary, we have revealed that different concentrations of Dex exposure during early gestation could exert a biphasic effect on vertebrate skeletal development.


Subject(s)
Bone and Bones/drug effects , Bone and Bones/embryology , Chondrocytes/drug effects , Dexamethasone/toxicity , Embryonic Development/drug effects , Animals , Cell Differentiation/drug effects , Cell Differentiation/physiology , Cell Proliferation/drug effects , Cell Proliferation/physiology , Cell Survival/drug effects , Cell Survival/physiology , Cells, Cultured , Chick Embryo , Chondrocytes/physiology , Dose-Response Relationship, Drug , Embryonic Development/physiology , Female , Glucocorticoids/toxicity , Pregnancy
10.
Bioorg Med Chem Lett ; 24(1): 367-70, 2014 Jan 01.
Article in English | MEDLINE | ID: mdl-24269165

ABSTRACT

This work describes the preparation of quinoline compounds as possible anti-bacterial agents. The synthesized quinoline derivatives show anti-bacterial activity towards Staphylococcus aureus. It is interesting to observe that the synthetic 5,7-dibromo-2-methylquinolin-8-ol (4) shows a similar minimum inhibitory concentration of 6.25Āµg/mL as compared to that of methicillin (3.125Āµg/mL) against Staphylococcus aureus.


Subject(s)
Anti-Bacterial Agents/pharmacology , Oxyquinoline/pharmacology , Staphylococcus aureus/drug effects , Anti-Bacterial Agents/chemical synthesis , Anti-Bacterial Agents/chemistry , Cell Death/drug effects , Cell Line , Dose-Response Relationship, Drug , Humans , Microbial Sensitivity Tests , Molecular Structure , Oxyquinoline/chemical synthesis , Oxyquinoline/chemistry , Structure-Activity Relationship
11.
Phytother Res ; 28(11): 1735-6, 2014 Nov.
Article in English | MEDLINE | ID: mdl-24719313

ABSTRACT

Ethanol has been commonly used as a vehicle for drug discovery purpose in vitro. The human breast cancer MCF-7 estrogen dependent cell line is a common in vitro model used for hormonal therapy study. However, special precaution is suggested when ethanol is used in pharmacological tests as solvent in order to evaluate the biological activity of potential drugs especially concerning about the MCF-7. Ethanol was shown to stimulate the proliferation of this estrogen receptor positive cell line. Here, we have further demonstrated that the dose responsive stimulatory effect of ethanol on the MCF-7 cells after pre-incubating the breast carcinoma cells with phenol red-free medium and stripped fetal bovine serum. Our findings open a discussion for the evaluation of ethanol as solvent for drug discovery and screening when using MCF-7 cells as a testing model.


Subject(s)
Cell Proliferation/drug effects , Drug Carriers/pharmacology , Ethanol/pharmacology , MCF-7 Cells/drug effects , Humans , Receptors, Estrogen/metabolism , Solvents/pharmacology
12.
Hum Reprod ; 28(9): 2363-71, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23787212

ABSTRACT

STUDY QUESTION: Is there a molecular link between Wnt signaling in fallopian tube inflammation and ectopic tubal implantation? SUMMARY ANSWER: Enhanced beta-catenin expression, reduced E-cadherin expression and glycogen accumulation in the tubal epithelia and hyperplasia in tubal arteries were found in ectopic tubal pregnancy, consistent with the effects induced by Wnt signaling and inflammation. WHAT IS KNOWN ALREADY: Chronic inflammation caused by infection can alter gene expression in the fallopian tube cells possibly leading to the development of ectopic pregnancy. Knockout mouse models have shown a relationship between Wnt/beta-catenin signaling and predisposition to tubal ectopic pregnancy. STUDY DESIGN, SIZE, DURATION: Women with ectopic tubal pregnancy (n = 18) were included in the case group, while women with chronic salpingitis (n = 13) and non-pregnant women undergoing sterilization procedures or salpingectomy for benign uterine disease (n = 10) were set as the controls. This study was performed between January 2012 and November 2012. PARTICIPANTS/MATERIALS, SETTING, METHODS: The ampullary segments of fallopian tubes were collected from patients. Tissues of tubal pregnancy were separated into implantation sites and non-implantation sites. Beta-catenin and E-cadherin expression were determined using immunohistological and immunofluorescence staining. Glycogen production was measured with periodic acid Schiff by staining. The diameter and wall thickness of tubal arteries were evaluated by histological analysis method. MAIN RESULTS AND THE ROLE OF CHANCE: Immunohistological staining revealed that beta-catenin protein expression was 100% positive in the ectopic pregnant and inflamed tubal tissues, and the staining intensity was significantly higher than in non-pregnant tubal tissues. In contrast, E-cadherin expression was reduced in ectopic pregnant fallopian tubes, possibly as a consequence of increased Wnt signaling. Moreover, glycogen accumulated in the tubal cells, and hyperplasia was observed in the tubal arteries with ectopic pregnancy, which is consistent with the effects induced by Wnt signaling and inflammation. All these changes could create the permissive environment that promotes embryos to ectopically implant into the fallopian tube. LIMITATIONS, REASONS FOR CAUTION: This finding requires a further confirmation about what activates Wnt signaling in ectopic tubal pregnancies. Also, it is generally recognized that Chlamydia infection is associated with ectopic pregnancy, and disturbs tubal epithelia via the Wnt signaling. However, the infection type in the samples used was salpingitis. WIDER IMPLICATIONS OF THE FINDINGS: A better understanding of the underlying mechanisms leading to ectopic pregnancies may contribute to our knowledge of the pathogenesis of tubal disorders and infertility and to the prevention of tubal ectopic pregnancy.


Subject(s)
Cadherins/metabolism , Fallopian Tubes/metabolism , Models, Biological , Mucous Membrane/metabolism , Pregnancy, Tubal/metabolism , Up-Regulation , beta Catenin/biosynthesis , Adult , Antigens, CD , Arteries/immunology , Arteries/pathology , Case-Control Studies , Disease Susceptibility , Down-Regulation , Fallopian Tube Diseases/immunology , Fallopian Tube Diseases/physiopathology , Fallopian Tubes/blood supply , Fallopian Tubes/immunology , Fallopian Tubes/pathology , Female , Glycogen/biosynthesis , Glycogen/metabolism , Humans , Hyperplasia , Mucous Membrane/blood supply , Mucous Membrane/immunology , Mucous Membrane/pathology , Neovascularization, Pathologic/etiology , Neovascularization, Pathologic/immunology , Neovascularization, Pathologic/metabolism , Neovascularization, Pathologic/physiopathology , Pregnancy , Pregnancy, Tubal/immunology , Pregnancy, Tubal/pathology , Pregnancy, Tubal/physiopathology , Wnt Signaling Pathway , beta Catenin/metabolism
13.
Bioorg Med Chem Lett ; 23(8): 2373-6, 2013 Apr 15.
Article in English | MEDLINE | ID: mdl-23473678

ABSTRACT

We explore the possible cellular cytotoxic activity of an amphiphilic silicon(IV) phthalocyanine with axially ligated rhodamine B under ambient light experimental environment as well as its in vivo antitumour potential using Hep3B hepatoma cell model. After loading into the Hep3B hepatoma cells, induction of cellular cytotoxicity and cell cycle arrest were detected. Strong growth inhibition of tumour xenograft together with significant tumour necrosis and limited toxicological effects exerted on the nude mice could be identified.


Subject(s)
Antineoplastic Agents/pharmacology , Indoles/chemistry , Indoles/pharmacology , Rhodamines/chemistry , Rhodamines/pharmacology , Silicon/pharmacology , Animals , Antineoplastic Agents/chemistry , Cell Line, Tumor , Humans , Isoindoles , Liver Neoplasms/drug therapy , Mice , Mice, Nude , Random Allocation , Silicon/chemistry , Xenograft Model Antitumor Assays
14.
Bioorg Med Chem Lett ; 22(9): 3213-8, 2012 May 01.
Article in English | MEDLINE | ID: mdl-22460032

ABSTRACT

Recently, we demonstrated the safety use of calendula oil/chitosan microcapsules as a carrier for both oral and topical deliveries. We also reported the improved biological activity towards skin cells and Staphylococcus aureus of phyllanthin containing chitosan microcapsules. However, the possibility of both oral and topical applications was still necessary to be further studied. Here we investigated that both oral and topical applications of chitosan-based microcapsules were tested using hydrocortisone succinic acid (HSA) and 5-fluorouracil (5-FU), respectively. The drug loading efficiency, particle size, surface morphology and chemical compositions of both drug loaded microcapsules were confirmed by UV-vis spectrophotometer, particle size analyzer, scanning electron microscope and Fourier transform infrared spectroscopy. The in vitro release studies revealed that both HSA and 5-FU could be released form chitosan microcapsules. The mean adrenocorticotropic hormone concentration in HSA loaded microcapsule mice plasma was detected to be lower than that of water control. One hundred micrograms per milliliter of 5-FU containing microcapsules exhibited a stronger growth inhibition towards skin keratinocytes than that of free 5-FU. In vitro drug delivery model demonstrated the delivery of 5-FU from microcapsule treated textiles into nude mice skin. Further uses of the drug loaded microcapsules may provide an efficiency deliverable tool for both oral and topical applications.


Subject(s)
Capsules/chemistry , Drug Delivery Systems/methods , Administration, Oral , Administration, Topical , Animals , Chitosan , Fluorouracil , Hydrocortisone , Keratinocytes/cytology , Mice , Skin/cytology , Skin/drug effects , Staphylococcus aureus , Succinic Acid
15.
Biochem Mol Biol Educ ; 49(4): 535-545, 2021 07.
Article in English | MEDLINE | ID: mdl-33682343

ABSTRACT

The benefits and long-term effects of extracurricular scientific research on undergraduate students in many countries have been intensively investigated, but it remains obscure for Chinese medical students. In this study, we investigated the outcome of 60 medical students who have participated in extracurricular scientific research at Jinan University Medical School over a period of 7 years (2011-2018). The results revealed that these students have contributed to 31 biomedical science articles in reputable academic journals, as first- or co-authors. Furthermore, they also independently procured various funding based on their research achievements, and smaller awards for achievements in conferences and competitions. Assessment of the grade point average score of these students revealed that conducting extracurricular scientific research did not affect their routine medical study and exam grades (P>0.05). The students benefited from participating in extracurricular research, by acquiring the ability to think scientifically and enhancing their communication skills. In addition, the medical students were motivated to enlist for postgraduate studies so that they could further embark in scientific research. In sum, Chinese medical students are capable of participating in scientific research and make a significant contribution to science.


Subject(s)
Biomedical Research/education , Biomedical Research/trends , Congenital Abnormalities/pathology , Education, Medical, Undergraduate/standards , Peer Review, Research/trends , Schools, Medical/statistics & numerical data , Students, Medical/psychology , Female , Humans , Male
16.
Biochem Biophys Res Commun ; 391(3): 1522-5, 2010 Jan 15.
Article in English | MEDLINE | ID: mdl-20035718

ABSTRACT

BRE, also known as TNFRSF1A modulator and BRCC45, is an evolutionarily highly conserved protein. It is a death receptor-associated protein in cytoplasm and a component of BRCA1/2-containing DNA repair complex in nucleus. BRE was found to have anti-apoptotic activity. Over-expression of BRE by transfection promoted survival of cell lines against apoptotic induction; whereas depletion of the protein by siRNA resulted in the opposite. In vivo anti-apoptotic activity of BRE was demonstrated by significant attenuation of Fas-induced acute fulminant hepatitis in transgenic mice expressing the human protein specifically in the liver. BRE was also implicated in tumor promotion by the accelerated tumor growth of Lewis Lung carcinoma transfected with human BRE; and by high expression of BRE specifically in the tumoral regions of human hepatocellular carcinoma (HCC). The present study was to test directly if transgenic expression of BRE in livers could promote HCC development in neonatal diethylnitrosamine model. By 8months after tumor induction, the maximal sizes of tumor nodules of transgenic mice were significantly larger than those of the non-transgenic controls, although the numbers of tumor nodules between the two groups did not significantly differ. Importantly, as in human HCC, the mouse endogenous BRE level was up-regulated in mouse HCC nodules. These results show that BRE over-expression can indeed promote growth, though not initiation, of liver tumors. Furthermore, the common occurrence of BRE over-expression in human and mouse HCC suggests that up-regulation of BRE is functionally important in liver tumor development.


Subject(s)
Carcinoma, Hepatocellular/pathology , Liver Neoplasms/pathology , Liver/pathology , Nerve Tissue Proteins/biosynthesis , Animals , Carcinoma, Hepatocellular/chemically induced , Carcinoma, Hepatocellular/metabolism , Cell Proliferation , Diethylnitrosamine/toxicity , Humans , Liver/metabolism , Liver Neoplasms/chemically induced , Liver Neoplasms/metabolism , Mice , Mice, Transgenic , Nerve Tissue Proteins/genetics , Transfection , Up-Regulation
17.
Mol Biol Rep ; 37(1): 363-8, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19757177

ABSTRACT

Stress-responsive genes play critical roles in many biological functions that includes apoptosis, survival, differentiation and regeneration. We have identified a novel stress-responsive gene called BRE which interacts with TNF-receptor-1 and blocks the apoptotic effect of TNF-alpha. BRE enhances tumor growth in vivo and is up-regulated in hepatocellular and esophageal carcinomas. BRE also regulates the ubiquitination of the DNA repair complex BRCC, and the synthesis of steroid hormones. Here, we examined BRE-mRNA in cells after treatments with UV and ionizing radiation (IR). UV and IR treatment alone suppressed BRE-mRNA levels by more than 90% at 24 h, while hydroxyurea, fluorodeoxyuridine, aphidicolin, known inhibitors of S-phase DNA synthesis, had no significant effect. BRE protein expression was unaltered in cells treated with TNF-alpha, Interleukin-1 and Dexamethasone, while a threefold increase was observed following chorionic gonadotropin exposure. Although BRE plays a regulatory role in many different pathways, yet its expression is apparently under very stringent control.


Subject(s)
Biological Factors/pharmacology , Gene Expression Regulation/drug effects , Nerve Tissue Proteins/genetics , Signal Transduction/drug effects , Stress, Physiological/drug effects , Stress, Physiological/genetics , Aphidicolin/pharmacology , Cadaverine/analogs & derivatives , Cadaverine/pharmacology , Cell Line , Chorionic Gonadotropin/pharmacology , DNA Ligase ATP , DNA Ligases/genetics , DNA Ligases/metabolism , Dexamethasone/pharmacology , Dimethyl Sulfoxide/pharmacology , Fluorodeoxyuridylate/pharmacology , Gene Expression Regulation/radiation effects , Humans , Hydroxyurea/pharmacology , Interleukin-1/pharmacology , Nerve Tissue Proteins/metabolism , Nuclear Proteins/genetics , Nuclear Proteins/metabolism , Promyelocytic Leukemia Protein , RNA, Messenger/genetics , RNA, Messenger/metabolism , Radiation, Ionizing , Signal Transduction/radiation effects , Stress, Physiological/radiation effects , Transcription Factors/genetics , Transcription Factors/metabolism , Tumor Necrosis Factor-alpha/pharmacology , Tumor Suppressor Proteins/genetics , Tumor Suppressor Proteins/metabolism , Ultraviolet Rays
18.
Biomedicines ; 8(10)2020 Oct 10.
Article in English | MEDLINE | ID: mdl-33050379

ABSTRACT

BRISC and BRCA1-A complex member 2 (Babam2) plays an essential role in promoting cell cycle progression and preventing cellular senescence. Babam2-deficient fibroblasts show proliferation defect and premature senescence compared with their wild-type (WT) counterpart. Pluripotent mouse embryonic stem cells (mESCs) are known to have unlimited cell proliferation and self-renewal capability without entering cellular senescence. Therefore, studying the role of Babam2 in ESCs would enable us to understand the mechanism of Babam2 in cellular aging, cell cycle regulation, and pluripotency in ESCs. For this study, we generated Babam2 knockout (Babam2-/-) mESCs to investigate the function of Babam2 in mESCs. We demonstrated that the loss of Babam2 in mESCs leads to abnormal G1 phase retention in response to DNA damage induced by gamma irradiation or doxorubicin treatments. Key cell cycle regulators, CDC25A and CDK2, were found to be degraded in Babam2-/- mESCs following gamma irradiation. In addition, Babam2-/- mESCs expressed p53 strongly and significantly longer than in control mESCs, where p53 inhibited Nanog expression and G1/S cell cycle progression. The combined effects significantly reduced developmental pluripotency in Babam2-/- mESCs. In summary, Babam2 maintains cell cycle regulation and pluripotency in mESCs in response to induced DNA damage.

19.
Cell Cycle ; 19(23): 3329-3347, 2020 12.
Article in English | MEDLINE | ID: mdl-33190590

ABSTRACT

Baicalin is a flavone glycoside that possesses numerous pharmacological properties. but its protective mode of action in kidney injury induced by diabetes mellitus remains incompletely understood. Using a streptozotocin (STZ)-induced diabetic mouse model, we found that baicalin could ameliorate diabetes-induced the pathological changes of the kidney function and morphology through suppressing inflammation and oxidative stress. Furthermore, baicalin treatment could alleviate interstitial fibrosis in the diabetic kidney via inhibiting epithelial-to-mesenchymal transition (EMT), which was accompanied by a sharp upregulation of Klotho, the endogenous inhibitor of renal fibrosis. We further verified that baicalin-rescued expression of Klotho was associated with Klotho promoter hypomethylation due to aberrant methyltransferase 3a expressions. Klotho knockdown via RNA interferences largely abrogated the anti-renal fibrotic effects of Baicalin in HK2 cells. These findings suggested that baicalin could alleviate renal injury-induced by diabates through partly modulating Klotho promoter methylation, which provides new insights into the treatment of diabetic nephropathy.


Subject(s)
Acute Kidney Injury/drug therapy , DNA Methylation/drug effects , Diabetes Mellitus, Experimental/drug therapy , Diabetes Mellitus, Type 1/drug therapy , Flavonoids/therapeutic use , Glucuronidase/antagonists & inhibitors , Acute Kidney Injury/metabolism , Animals , DNA Methylation/physiology , Diabetes Mellitus, Experimental/metabolism , Diabetes Mellitus, Type 1/metabolism , Female , Flavonoids/pharmacology , Glucuronidase/biosynthesis , Klotho Proteins , Mice , Oxidative Stress/drug effects , Oxidative Stress/physiology
SELECTION OF CITATIONS
SEARCH DETAIL